Human papillomavirus antibody responses among patients with incident cervical carcinoma

Journal of Medical Virology

Volumn 52, Issue 4, 1997, Pages 436-440

  Wang, Zhaohui ^a   Konya, Jozsef ^a   Åvall Lundkvist, Elisabeth ^b   Sapp, Martin ^c   Dillner, Joakim ^a   Dillner, Lena ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

ELISA; Seroepidemiology; Tumor virology

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; SEROPREVALENCE; UTERINE CERVIX CARCINOMA; VIRUS CAPSID; VIRUS CARCINOGENESIS; VIRUS STRAIN; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID; CASE-CONTROL STUDIES; EPITOPES; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; MIRIDAE;

EID: 0030737969     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199708)52:4<436::AID-JMV16>3.0.CO;2-E     Document Type: Article

References (31)

1. Andersson-Ellström A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman L, Milsom I (1996): Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sexually Transmitted Diseases 23:234-238.
2. Christensen ND, Kreider JW, Cladel NM, Patrick SD, Welsh PA (1990): Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. Journal of Virology 64:5678-5681.
3. Chua K, Wiklund F, Lenner P, Ångström T, Hallmans G, Bergman F, Sapp M, Schiller J, Wadell G, Hjerpe A, Dillner J (1996): A prospective cohort study on the risk to develop cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV, in comparison with presence of HPV DNA in cervical smears. International Journal of Cancer 68:54-59.
4. Dillner J (1990): Mapping of linear epitopes of the human papillomavirus type 16: The E1, E2, E4, E5, E6 and E7 open reading frames. International Journal of Cancer 46:703-711.
5. Dillner J (1993): Disappearance of antibodies to HPV16 E7 after treatment for cervical cancer. Lancet 341:1594.
6. Dillner J (1994): Antibody responses to defined HPV epitopes in cervical neoplasia. Papillomavirus Report 5:35-41.
7. Dillner J (1995): Serology of human papillomavirus. Cancer Journal 8:264-269.
8. Dillner J (1997): Prospects for vaccination. In Gross G, von Krogh G (eds): "Human Papillomavirus Infections in Dermatovenereology." Boca Raton, FL: CRC Press, pp 417-430.
9. Dillner J, Dillner L, Robb J, Willems J, Jones I, Lancaster W, Smith R, Lerner R (1989): A synthetic peptide defines a serologic IgA response to a human papillomavirus-carrying cervical neoplasia. Proceedings of the National Academy of Sciences USA 86:3838-3841.
10. Dillner J, Lenner P, Lehtinen M, Eklund C, Heino P, Wiklund F, Hallmans G, Stendahl U (1994): A population-based seroepidemiological study of cervical cancer. Cancer Research 54:134-141.
11. Dillner J, Wiklund F, Lenner P, Eklund C, Fredriksson-Shanazarian V, Schiller JT, Hibma M, Hallmans G, Stendahl U (1995a): Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with cervical cancer. International Journal of Cancer 60:377-382.
12. Dillner J, Knekt P, Schiller JT, Hakulinen T (1995b): Prospective seroepidemiological evidence that Human Papillomavirus type 16 infection is a risk factor for esophageal squamous cell carcinoma. British Medical Journal 311:1346.
13. Dillner J, Kallings I, Brihmer C, Sikström B, Koskela P, Lehtinen M, Schiller JT, Sapp M, Mårdh PA (1996): Seropositivity to human papillomavirus types 16, 18 or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. Journal of Infectious Diseases 173:1394-1398.
14. Dillner L, Bekassy Z, Jonsson N, Moreno-Lopez J, Blomberg J (1989): Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. International Journal of Cancer 43:36-40.
15. Dillner L, Zellbi A, Åvall-Lundkvist E, Heino P, Pettersson CA, Hansson BG, Forslund O, Grandien M, Bistoletti P, Dillner J (1995): Association of serum antibodies against defined epitopes of human papillomavirus L1, E2 and E7 antigens and of HPV DNA with incident cervical cancer. Cancer Detection and Prevention 19:381-393.
16. Elfgren K, Bistoletti P, Dillner L, Walboomers JMM, Meijer CJLM, Dillner J (1996): Conization of CIN is followed by a disappearance of HPV DNA and a decline of serum and cervical mucus antibodies against HPV antigens. American Journal of Obstetrics and Gynecology 174:937-994.
17. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J (1994): Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: Implications for STD epidemiology. International Journal of Sexually Transmitted Diseases and AIDS 5:113-116.
18. Heino P, Eklund C, Fredriksson-Shahnazarian V, Goldman S, Schiller JT, Dillner J (1995a): Association of serum IgG antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. JNCI 87:437-440.
19. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT (1994): A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. JNCI 86:494-499.
20. Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, Koskela P, Paavonen J, Peto R, Schiller JT, Hakama M (1996): Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma. British Medical Journal 312:537-539.
21. Lenner P, Dillner J, Wiklund F, Hallmans G, Stendahl U (1995): Serum antibody levels against human papillomavirus antigens in relation to tumor characteristics, response to treatment and survival in carcinoma of the uterine cervix. Cancer Immunology and Immunotherapy 40:201-205.
22. Nonnenmacher B, Hubbert NL, Kirnbauer R, Shah KV, Munoz N, Bosch FX, de Sanjose S, Viscidi R, Lowy DR, Schiller JT (1995): Serologic response to human papillomavirus type 16 virus-like particles in HPV 16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. Journal of Infectious Diseases 172:19-24.
23. Nonnenmacher B, Kruger Kjaer S, Svare EI, Scott JD, Hubbert NL, van den Brule AJC, Kirnbauer R, Walboomers JMM, Lowy DR (1996): Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations. International Journal of Cancer 68:704-709.
24. Olsen AO, Dillner J, Gjöen K, Sauer T, Örstavik I, Magnus P (1996): A population-based case-control study of human papillomavirus type 16 seropositivity and incident high-grade dysplasia of the uterine cervix. International Journal of Cancer 68:415-419.
25. Persson K, Månsson A, Jönsson E, Nordenfelt E (1995): Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scandinavian Journal of Infectious Diseases 27:195-199.
26. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott PR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos MM (1993): Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. JNCI 85:958-964.
27. Strickler HD, Schiffman MH, Eklund C, Glass AG, Lörincz AT, Scott DR, Sherman ME, Kurman RJ, Manos M, Schiller J, Dillner J (1997): Characterization of HPV antibody responses to squamous intraepithelial lesions of the cervix. Cancer Epidemiology Biomarkers and Prevention (6:183-188.
28. Volpers C, Schirmacher P, Streeck RE, Sapp M (1994): Assembly of the major and minor capsid proteins of HPV type 33 into virus-like particles and tubular structures in insect cells. Virology 200:504-512.
29. Wideroff L, Schiffman MH, Nonenmacher B, Hubbert NKR, Greer CE, Lowy D, Lorincz AT, Manos MM, Glass AG, Scott DR, Sherman ME, Kurman RT, Buckland J, Tarone RE, Schiller J (1995): Evaluation of seroreactivity to HPV16 virus like-particles in an incident case-control study of cervical neoplasia. Journal of Infectious Diseases 172:1425-1430.
30. Wikström A, Van Doornum GJJ, Quint WGV, Schiller JT, Dillner J (1995): Identification of human papillomavirus seroconversions. Journal of General Virology 76:529-539.
31. zur Hausen H (1991): Viruses in human cancers. Science 254:1167-1173.